vs
ARDELYX, INC.（ARDX）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
RESOURCES CONNECTION, INC.的季度营收约是ARDELYX, INC.的1.2倍（$117.7M vs $94.5M），RESOURCES CONNECTION, INC.净利率更高（-10.8% vs -39.8%，领先29.1%），ARDELYX, INC.同比增速更快（27.5% vs -19.2%），过去两年ARDELYX, INC.的营收复合增速更高（13.6% vs -11.8%）
Ardelyx是一家商业化阶段的生物制药企业，专注于研发和商业化针对胃肠道、心肾及代谢类疾病的创新疗法，其核心产品已在美国获批用于治疗便秘型肠易激综合征，同时拥有涵盖多适应症的各阶段研发管线。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
ARDX vs RGP — 直观对比
营收规模更大
RGP
是对方的1.2倍
$94.5M
营收增速更快
ARDX
高出46.6%
-19.2%
净利率更高
RGP
高出29.1%
-39.8%
两年增速更快
ARDX
近两年复合增速
-11.8%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $94.5M | $117.7M |
| 净利润 | $-37.6M | $-12.7M |
| 毛利率 | — | 37.1% |
| 营业利润率 | — | -10.3% |
| 净利率 | -39.8% | -10.8% |
| 营收同比 | 27.5% | -19.2% |
| 净利润同比 | — | 81.6% |
| 每股收益（稀释后） | $-0.15 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARDXRGP
| Q1 26 | $94.5M | — | ||
| Q4 25 | $125.2M | $117.7M | ||
| Q3 25 | $110.3M | $120.2M | ||
| Q2 25 | $97.7M | $139.3M | ||
| Q1 25 | $74.1M | $129.4M | ||
| Q4 24 | $116.1M | $145.6M | ||
| Q3 24 | $98.2M | $136.9M | ||
| Q2 24 | $73.2M | $148.2M |
净利润ARDXRGP
| Q1 26 | $-37.6M | — | ||
| Q4 25 | $-407.0K | $-12.7M | ||
| Q3 25 | $-969.0K | $-2.4M | ||
| Q2 25 | $-19.1M | $-73.3M | ||
| Q1 25 | $-41.1M | $-44.1M | ||
| Q4 24 | $4.6M | $-68.7M | ||
| Q3 24 | $-809.0K | $-5.7M | ||
| Q2 24 | $-16.5M | $10.5M |
毛利率ARDXRGP
| Q1 26 | — | — | ||
| Q4 25 | 91.3% | 37.1% | ||
| Q3 25 | 96.4% | 39.5% | ||
| Q2 25 | 87.3% | 40.2% | ||
| Q1 25 | 83.4% | 35.1% | ||
| Q4 24 | 84.3% | 38.5% | ||
| Q3 24 | 84.0% | 36.5% | ||
| Q2 24 | 87.1% | 40.2% |
营业利润率ARDXRGP
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | -10.3% | ||
| Q3 25 | 4.2% | -1.7% | ||
| Q2 25 | -14.7% | -47.0% | ||
| Q1 25 | -49.0% | -38.4% | ||
| Q4 24 | 7.0% | -52.7% | ||
| Q3 24 | 2.3% | -3.5% | ||
| Q2 24 | -18.6% | 7.6% |
净利率ARDXRGP
| Q1 26 | -39.8% | — | ||
| Q4 25 | -0.3% | -10.8% | ||
| Q3 25 | -0.9% | -2.0% | ||
| Q2 25 | -19.5% | -52.6% | ||
| Q1 25 | -55.5% | -34.0% | ||
| Q4 24 | 4.0% | -47.2% | ||
| Q3 24 | -0.8% | -4.2% | ||
| Q2 24 | -22.5% | 7.1% |
每股收益（稀释后）ARDXRGP
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-0.01 | $-0.38 | ||
| Q3 25 | $0.00 | $-0.07 | ||
| Q2 25 | $-0.08 | $-2.21 | ||
| Q1 25 | $-0.17 | $-1.34 | ||
| Q4 24 | $0.01 | $-2.08 | ||
| Q3 24 | $0.00 | $-0.17 | ||
| Q2 24 | $-0.07 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.1M | $89.8M |
| 总债务越低越好 | $203.5M | — |
| 股东权益账面价值 | $148.6M | $194.6M |
| 总资产 | $504.5M | $289.3M |
| 负债/权益比越低杠杆越低 | 1.37× | — |
8季度趋势，按日历期对齐
现金及短期投资ARDXRGP
| Q1 26 | $238.1M | — | ||
| Q4 25 | $68.0M | $89.8M | ||
| Q3 25 | $42.7M | $77.5M | ||
| Q2 25 | $90.0M | $86.1M | ||
| Q1 25 | $30.8M | $72.5M | ||
| Q4 24 | $64.9M | $78.2M | ||
| Q3 24 | $47.4M | $89.6M | ||
| Q2 24 | $41.9M | $108.9M |
总债务ARDXRGP
| Q1 26 | $203.5M | — | ||
| Q4 25 | $202.8M | — | ||
| Q3 25 | $202.1M | — | ||
| Q2 25 | $201.4M | — | ||
| Q1 25 | $151.3M | — | ||
| Q4 24 | $150.9M | — | ||
| Q3 24 | $100.7M | — | ||
| Q2 24 | $100.2M | — |
股东权益ARDXRGP
| Q1 26 | $148.6M | — | ||
| Q4 25 | $166.9M | $194.6M | ||
| Q3 25 | $154.3M | $206.4M | ||
| Q2 25 | $139.5M | $207.1M | ||
| Q1 25 | $145.7M | $277.8M | ||
| Q4 24 | $173.3M | $325.7M | ||
| Q3 24 | $158.3M | $407.2M | ||
| Q2 24 | $147.0M | $418.8M |
总资产ARDXRGP
| Q1 26 | $504.5M | — | ||
| Q4 25 | $501.6M | $289.3M | ||
| Q3 25 | $486.2M | $287.2M | ||
| Q2 25 | $466.8M | $304.7M | ||
| Q1 25 | $410.2M | $375.6M | ||
| Q4 24 | $435.8M | $424.9M | ||
| Q3 24 | $367.9M | $512.9M | ||
| Q2 24 | $343.5M | $510.9M |
负债/权益比ARDXRGP
| Q1 26 | 1.37× | — | ||
| Q4 25 | 1.21× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 1.44× | — | ||
| Q1 25 | 1.04× | — | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $15.9M |
| 自由现金流经营现金流 - 资本支出 | — | $15.6M |
| 自由现金流率自由现金流/营收 | — | 13.2% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $24.3M |
8季度趋势，按日历期对齐
经营现金流ARDXRGP
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $15.9M | ||
| Q3 25 | $365.0K | $-7.8M | ||
| Q2 25 | $-25.3M | $16.8M | ||
| Q1 25 | $-38.5M | $659.0K | ||
| Q4 24 | $9.8M | $1.8M | ||
| Q3 24 | $501.0K | $-309.0K | ||
| Q2 24 | $-19.4M | $3.2M |
自由现金流ARDXRGP
| Q1 26 | — | — | ||
| Q4 25 | $20.6M | $15.6M | ||
| Q3 25 | $209.0K | $-8.0M | ||
| Q2 25 | $-26.0M | $16.5M | ||
| Q1 25 | $-38.8M | $238.0K | ||
| Q4 24 | $9.2M | $61.0K | ||
| Q3 24 | $364.0K | $-575.0K | ||
| Q2 24 | $-19.5M | $3.0M |
自由现金流率ARDXRGP
| Q1 26 | — | — | ||
| Q4 25 | 16.4% | 13.2% | ||
| Q3 25 | 0.2% | -6.6% | ||
| Q2 25 | -26.6% | 11.8% | ||
| Q1 25 | -52.3% | 0.2% | ||
| Q4 24 | 7.9% | 0.0% | ||
| Q3 24 | 0.4% | -0.4% | ||
| Q2 24 | -26.7% | 2.1% |
资本支出强度ARDXRGP
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 0.3% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.7% | 0.2% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 0.5% | 1.2% | ||
| Q3 24 | 0.1% | 0.2% | ||
| Q2 24 | 0.2% | 0.1% |
现金转化率ARDXRGP
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.11× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.30× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
